Federation des caisses Desjardins du Quebec’s Ligand Pharmaceuticals LGND Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-56	Closed	-$4K	–	2309
2019 Q2	$4K	Sell	56 -2,220	-98%	-$164K	﹤0.01%	2035
2019 Q1	$178K	Sell	2,276 -731	-24%	-$55.4K	﹤0.01%	1006
2018 Q4	$255K	Sell	3,007 -26	-0.9%	-$2.77K	﹤0.01%	902
2018 Q3	$519K	Sell	3,033 -67	-2%	-$10.1K	0.01%	742
2018 Q2	$401K	Buy	+3,100	New	+$346K	0.01%	813
2018 Q1	–	Sell	-398	Closed	-$34K	–	2187
2017 Q4	$34K	Sell	398 -1,165	-75%	-$101K	﹤0.01%	1447
2017 Q3	$133K	Sell	1,563 -409	-21%	-$32.4K	﹤0.01%	1093
2017 Q2	$149K	Buy	+1,972	New	+$138K	﹤0.01%	1090

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's LGND Position: Q3 2019 in Review

Federation des caisses Desjardins du Quebec sold out of Ligand Pharmaceuticals (LGND) in Q3 2019, closing a stake of 56 shares — an estimated $4K sold.

Federation des caisses Desjardins du Quebec first reported a position in LGND in Q2 2017 and held it in 8 quarters. The position peaked at $519K in Q3 2018. 275 funds tracked by Wall St. Rank hold LGND as of Q3 2019.

Federation des caisses Desjardins du Quebec reported no remaining Ligand Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 56 Ligand Pharmaceuticals shares in Q3 2019, an estimated $4K.
Federation des caisses Desjardins du Quebec first reported a position in Ligand Pharmaceuticals in Q2 2017 and held it in 8 quarters.
Federation des caisses Desjardins du Quebec's Ligand Pharmaceuticals position peaked at $519K in Q3 2018.
275 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2019.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2019, filed 30 Aug 2024.